nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Cell-Based Renilla Luminescence Reporter Plasmid Assay for High-Throughput Screening to Identify Novel FDA-Approved Drug Inhibitors of HPV-16 Infection
|
Walhart, Tara |
|
|
|
1 |
p. 79-86 |
artikel |
2 |
A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate Aldolase
|
Cho, Eun Jeong |
|
2018 |
|
1 |
p. 1-10 |
artikel |
3 |
A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1
|
McNulty, Dean E. |
|
2018 |
|
1 |
p. 34-46 |
artikel |
4 |
A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1
|
Müller, Leonie |
|
|
|
1 |
p. 3-11 |
artikel |
5 |
A High-Throughput Screening Strategy to Identify Inhibitors of SSB Protein–Protein Interactions in an Academic Screening Facility
|
Voter, Andrew F. |
|
2018 |
|
1 |
p. 94-101 |
artikel |
6 |
A High-Throughput Screening Triage Workflow to Authenticate a Novel Series of PFKFB3 Inhibitors
|
St-Gallay, Stephen A. |
|
2018 |
|
1 |
p. 11-22 |
artikel |
7 |
Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota
|
Yang, Wei |
|
2018 |
|
1 |
p. 76-83 |
artikel |
8 |
Aqueous Solubility Enhancement for Bioassays of Insoluble Inhibitors and QSPR Analysis: A TNF-α Study
|
Mettou, Anthi |
|
2018 |
|
1 |
p. 84-93 |
artikel |
9 |
A Rapid Phenotypic Whole-Cell Screening Approach for the Identification of Small-Molecule Inhibitors That Counter β-Lactamase Resistance in Pseudomonas aeruginosa
|
Collia, Deanna |
|
2018 |
|
1 |
p. 55-64 |
artikel |
10 |
A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation
|
Cote, Shaun M. |
|
|
|
1 |
p. 95-103 |
artikel |
11 |
Characterization and comparison of hypoxia inducing factors on tumor growth and metastasis between two- and three-dimensional cancer models
|
Chan, Leo Li-Ying |
|
|
|
1 |
p. 59-65 |
artikel |
12 |
Consideration of vendor-related differences in hepatic metabolic stability data to optimize early ADME screening in drug discovery
|
Shah, Pranav |
|
|
|
1 |
p. 34-39 |
artikel |
13 |
Corrigendum to DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ [SLAS Discov. 2022 Sep 5;S2472-5552(22)13691-9. doi: 10.1016/j.slasd.2022.08.004.]
|
Liu, Liang |
|
|
|
1 |
p. 48 |
artikel |
14 |
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening
|
Lee, Olivia W. |
|
|
|
1 |
p. 9-20 |
artikel |
15 |
Deep Learning Image Analysis of High-Throughput Toxicology Assay Images
|
Tandon, Arpit |
|
|
|
1 |
p. 29-38 |
artikel |
16 |
Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines
|
Close, David A. |
|
|
|
1 |
p. 39-54 |
artikel |
17 |
Development and Implementation of an HTS-Compatible Assay for the Discovery of Selective Small-Molecule Ligands for Pre-microRNAs
|
Lorenz, Daniel A. |
|
2018 |
|
1 |
p. 47-54 |
artikel |
18 |
Development of a Bioluminescent High-Throughput Screening Assay for Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)
|
Haubrich, Brad A. |
|
|
|
1 |
p. 33-42 |
artikel |
19 |
Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK–Paxillin Interaction
|
Marlowe, Timothy |
|
|
|
1 |
p. 21-32 |
artikel |
20 |
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant
|
Larson, Jacob E. |
|
|
|
1 |
p. 39-47 |
artikel |
21 |
Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia
|
Salani, Monica |
|
2019 |
|
1 |
p. 57-67 |
artikel |
22 |
Development of High-Throughput Screening Assays for Inhibitors of ETS Transcription Factors
|
Currie, Simon L. |
|
2019 |
|
1 |
p. 77-85 |
artikel |
23 |
DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ
|
Liu, Liang |
|
|
|
1 |
p. 19-28 |
artikel |
24 |
DNA Switch: Toehold-Mediated DNA Isothermal Amplification for Dengue Serotyping
|
Chan, Soo Khim |
|
2019 |
|
1 |
p. 68-76 |
artikel |
25 |
Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells
|
DeHart, David N. |
|
2018 |
|
1 |
p. 23-33 |
artikel |
26 |
Fragment-based screening: A new paradigm for ligand and target discovery
|
Knight, Sinéad |
|
|
|
1 |
p. 3-7 |
artikel |
27 |
Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells
|
Barlan, Kari |
|
|
|
1 |
p. 52-58 |
artikel |
28 |
High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes
|
Kassner, Michelle |
|
|
|
1 |
p. 68-76 |
artikel |
29 |
High-Throughput cell-based immunofluorescence assays against influenza
|
Martinez-Gzegozewska, Yohanka |
|
|
|
1 |
p. 66-76 |
artikel |
30 |
High-throughput screening for identifying acetylcholinesterase inhibitors: Insights on novel inhibitors and the use of liver microsomes
|
Santillo, Michael F. |
|
|
|
1 |
p. 65-67 |
artikel |
31 |
Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput Screening
|
Zhu, Hu |
|
|
|
1 |
p. 43-56 |
artikel |
32 |
Identification of Antimalarial Inhibitors Using Late-Stage Gametocytes in a Phenotypic Live/Dead Assay
|
Spicer, Timothy P. |
|
2019 |
|
1 |
p. 38-46 |
artikel |
33 |
Identification of Chemical Compounds That Inhibit the Function of Histidyl-tRNA Synthetase from Pseudomonas aeruginosa
|
Hu, Yanmei |
|
2018 |
|
1 |
p. 65-75 |
artikel |
34 |
Identification of positive modulators of TRPM5 channel from a high-throughput screen using a fluorescent membrane potential assay
|
Virginio, Caterina |
|
|
|
1 |
p. 55-64 |
artikel |
35 |
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
|
Mediouni, Sonia |
|
|
|
1 |
p. 8-19 |
artikel |
36 |
Identification of Primary Natural Killer Cell Modulators by Chemical Library Screening with a Luciferase-Based Functional Assay
|
Hayek, Simon |
|
2019 |
|
1 |
p. 25-37 |
artikel |
37 |
Key aspects of modern GPCR drug discovery
|
Addis, Phil |
|
|
|
1 |
p. 1-22 |
artikel |
38 |
Lysyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization and Identification of Inhibitory Compounds
|
Balboa, Samantha |
|
|
|
1 |
p. 57-69 |
artikel |
39 |
Morphology-Based Analysis of Myoblasts for Prediction of Myotube Formation
|
Ishikawa, Kiyoshi |
|
2019 |
|
1 |
p. 47-56 |
artikel |
40 |
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors
|
FitzGerald, Edward A. |
|
|
|
1 |
p. 40-51 |
artikel |
41 |
Novel Cell-Based Assay for Identification of LRRK2 Inhibitors Using Its Aberrant Regulation of a Pluripotency Gene
|
Ramonet, David |
|
|
|
1 |
p. 104-112 |
artikel |
42 |
Optimising cell-based bioassays via integrated design of experiments (ixDoE) - A practical guide
|
Solzin, J |
|
|
|
1 |
p. 29-38 |
artikel |
43 |
Rebuttal to Response to the Article “Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality”
|
Copeland, Robert A. |
|
|
|
1 |
p. 8 |
artikel |
44 |
Reduced levels of serum EPA and DHA identified in patients with non-small-cell lung cancer using a new rapid validated LC-MS/MS method
|
Wang, Yi |
|
|
|
1 |
p. 12-18 |
artikel |
45 |
Response to the Article “Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality”
|
Walsh, Ryan |
|
|
|
1 |
p. 7 |
artikel |
46 |
Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis
|
Eniyan, Kandasamy |
|
|
|
1 |
p. 70-78 |
artikel |
47 |
Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals
|
Van Vleet, Terry R. |
|
2019 |
|
1 |
p. 1-24 |
artikel |
48 |
SLAS Discovery – The Next Generation of Research
|
Jump, Ally |
|
|
|
1 |
p. 1-2 |
artikel |
49 |
SLAS Discovery—What’s in a Name?
|
Campbell, Robert M. |
|
|
|
1 |
p. 1 |
artikel |
50 |
The National Cancer Institute’s Plated Compound Sets Can Be a Valuable Resource for Academic Researchers
|
Zweifach, Adam |
|
|
|
1 |
p. 2-6 |
artikel |
51 |
Therapeutic approaches for Type 1 Diabetes: Promising cell-based approaches to achieve ultimate success
|
Sepyani, Sahar |
|
|
|
1 |
p. 23-33 |
artikel |
52 |
The SLAS Discovery Editor's Top 10 for 2022
|
Campbell, Robert M. |
|
|
|
1 |
p. 1-2 |
artikel |
53 |
Three-Dimensional Control of Ion Channel Function through Optogenetics and Co-Culture
|
Agus, Viviana |
|
2018 |
|
1 |
p. 102-108 |
artikel |
54 |
Toward Label-Free SERS Detection of Proteins through Their Disulfide Bond Structure
|
Hassanain, Waleed A. |
|
|
|
1 |
p. 87-94 |
artikel |
55 |
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies
|
Satapati, Santhosh |
|
|
|
1 |
p. 20-28 |
artikel |
56 |
Virtual plates: Getting the best out of high content screens
|
Shapira Lots, Inbal |
|
|
|
1 |
p. 77-85 |
artikel |